Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1

NCT03959189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy, Type 1 (DM1)
Myotonic Dystrophy

Interventions

DRUG: ERX-963
DRUG: Placebo

Sponsor

Expansion Therapeutics, Inc.